VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GLGlobe Life Inc.
$179.25$13.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGLQuarterly Financials

Globe Life Inc. (GL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Globe Life Inc. (GL) quarterly income statement — complete revenue, gross profit & net income history

GL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Revenue1.56B1.52B1.51B1.48B1.48B1.47B1.46B1.44B1.42B1.42B1.38B1.33B
Revenue Growth %5.35%3.93%3.96%2.85%4.54%3.57%5.15%8.58%29.51%7.03%6.7%2.68%
Medical Costs & Claims789.58M1.06B888.19M1.02B1.02B998.84M942.19M987.41M741.3M964.58M953.48M950.05M
Medical Cost Ratio %50.63%69.64%58.7%69.18%68.94%68.12%64.74%68.56%52.35%68.13%68.89%71.63%
Gross Profit770.03M462.61M624.8M456.48M459.82M467.44M513.22M452.83M674.84M451.11M430.64M376.36M
Gross Margin %49.37%30.36%41.3%30.82%31.06%31.88%35.26%31.44%47.65%31.87%31.11%28.37%
Gross Profit Growth %67.46%-1.03%21.74%0.8%-31.86%3.62%19.18%20.32%76.07%20.75%24.15%-2.98%
Operating Expenses401.9M106.35M147.7M143.18M143.74M155.01M136.26M130.51M359.92M114.4M111.83M111.85M
OpEx / Revenue %25.77%6.98%9.76%9.67%9.71%10.57%9.36%9.06%25.42%8.08%8.08%8.43%
Depreciation & Amortization000000000000
Combined Ratio %76.4%76.62%68.47%78.85%78.65%78.69%74.1%77.62%77.76%76.22%76.97%80.06%
Operating Income368.13M356.26M477.1M313.3M316.08M312.43M376.96M322.32M314.92M336.71M318.81M264.51M
Operating Margin %23.6%23.38%31.53%21.15%21.35%21.31%25.9%22.38%22.24%23.78%23.03%19.94%
Operating Income Growth %16.47%14.03%26.57%-2.8%0.37%-7.21%18.24%21.86%14.84%30.65%35.8%-4.32%
EBITDA368.13M379.27M513.24M348.18M351.07M348.13M408.35M353.73M343.53M362.39M344.77M290.32M
EBITDA Margin %23.6%24.89%33.92%23.51%23.71%23.74%28.06%24.56%24.26%25.6%24.91%21.89%
Interest Expense34M35.21M36.13M34.88M34.99M35.7M31.39M31.4M28.61M25.68M25.95M25.82M
Non-Operating Income0-23.01M-36.13M-34.88M-34.99M-35.7M-31.39M-31.4M-28.61M-25.68M-25.95M-25.82M
Pretax Income334.13M333.25M477.1M313.3M316.08M312.43M376.96M322.32M314.92M336.71M318.81M264.51M
Pretax Margin %21.42%21.87%31.53%21.15%21.35%21.31%25.9%22.38%22.24%23.78%23.03%19.94%
Income Tax63.61M67.25M89.26M60.55M61.52M57.24M73.96M63.97M60.71M61.91M61.73M49.25M
Effective Tax Rate %19.04%20.18%18.71%19.33%19.46%18.32%19.62%19.85%19.28%18.39%19.36%18.62%
Net Income270.53M266M387.84M252.75M254.56M255.2M302.99M258.36M254.22M274.8M257.08M215.26M
Net Margin %17.35%17.45%25.63%17.06%17.2%17.4%20.82%17.94%17.95%19.41%18.57%16.23%
Net Income Growth %6.27%4.23%28%-2.17%0.14%-7.13%17.86%20.02%13.69%29.89%34.89%-3.89%
EPS (Diluted)3.453.294.713.053.013.013.442.832.672.882.682.24
EPS Growth %14.62%9.3%36.92%7.77%12.73%4.51%28.36%26.34%17.11%34.58%41.05%-0.89%
EPS (Basic)3.453.354.813.093.053.043.452.832.712.882.722.26
Diluted Shares Outstanding79.8M80.85M82.02M82.79M84.48M84.75M88.09M93.87M95.11M95.46M95.82M96.25M